Cargando…
Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis
PURPOSE: The objective of this study was to determine the toxicities and outcomes of patients with spinal metastasis treated with external beam radiation therapy (EBRT) to 25 Gy in 5 fractions. METHODS AND MATERIALS: Data were extracted from an institutional tumor registry for patients with spinal m...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917266/ https://www.ncbi.nlm.nih.gov/pubmed/35287317 http://dx.doi.org/10.1016/j.adro.2022.100906 |
_version_ | 1784668511113576448 |
---|---|
author | Shin, Jacob Y. Mathis, Noah J. Wijetunga, Neil Ari Yerramilli, Divya Higginson, Daniel S. Schmitt, Adam M. Gomez, Daniel R. Yamada, Yoshiya J. Yang, Jonathan T. |
author_facet | Shin, Jacob Y. Mathis, Noah J. Wijetunga, Neil Ari Yerramilli, Divya Higginson, Daniel S. Schmitt, Adam M. Gomez, Daniel R. Yamada, Yoshiya J. Yang, Jonathan T. |
author_sort | Shin, Jacob Y. |
collection | PubMed |
description | PURPOSE: The objective of this study was to determine the toxicities and outcomes of patients with spinal metastasis treated with external beam radiation therapy (EBRT) to 25 Gy in 5 fractions. METHODS AND MATERIALS: Data were extracted from an institutional tumor registry for patients with spinal metastasis who were treated with EBRT to 25 Gy in 5 fractions to their spinal lesion(s). Cox regression and Kaplan-Meier analyses to determine local control and overall survival (OS) were employed. RESULTS: Seventy-five patients with 86 total treated spinal metastatic tumors were identified. The median follow-up was 7 months. The median age was 66 years. Fifty-six patients (75.7%) experienced partial or complete pain relief for a median duration of 6 months (range, 1-33). Fifty-one (59.3%) cases were planned using intensity modulated radiation therapy while 19 (22.1%) employed 3-dimensional conformal radiation therapy and 16 (18.6%) cases used nonconformal radiation technique. Greater than 90% of cases had a point dose maximum to the spinal cord/cauda equina <27.5 Gy. No patient experienced treatment-related myelopathy. The most common toxicities were fatigue (23.3%), pain flare (14.0%), and nausea (8.1%). There were no grade 3 toxicities. One-year local control was 80.6%, and 1-year OS was 38.4%. Higher Karnofsky performance status (P = .001) and radiosensitive tumor histology (P = .014) were significant predictors for better OS. CONCLUSIONS: Our single-institutional retrospective analysis of patients with spinal metastasis suggested that palliative EBRT to 25 Gy in 5 fractions is safe, with a low toxicity profile and minimal risk for myelopathy with an achievable dose maximum to the spinal cord and cauda equina ≤27 Gy (equivalent total dose in 2-Gy fractions ≤50 Gy), and it may provide durable palliation and local control in cases where stereotactic body radiation therapy may not be indicated. |
format | Online Article Text |
id | pubmed-8917266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-89172662022-03-13 Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis Shin, Jacob Y. Mathis, Noah J. Wijetunga, Neil Ari Yerramilli, Divya Higginson, Daniel S. Schmitt, Adam M. Gomez, Daniel R. Yamada, Yoshiya J. Yang, Jonathan T. Adv Radiat Oncol Scientific Article PURPOSE: The objective of this study was to determine the toxicities and outcomes of patients with spinal metastasis treated with external beam radiation therapy (EBRT) to 25 Gy in 5 fractions. METHODS AND MATERIALS: Data were extracted from an institutional tumor registry for patients with spinal metastasis who were treated with EBRT to 25 Gy in 5 fractions to their spinal lesion(s). Cox regression and Kaplan-Meier analyses to determine local control and overall survival (OS) were employed. RESULTS: Seventy-five patients with 86 total treated spinal metastatic tumors were identified. The median follow-up was 7 months. The median age was 66 years. Fifty-six patients (75.7%) experienced partial or complete pain relief for a median duration of 6 months (range, 1-33). Fifty-one (59.3%) cases were planned using intensity modulated radiation therapy while 19 (22.1%) employed 3-dimensional conformal radiation therapy and 16 (18.6%) cases used nonconformal radiation technique. Greater than 90% of cases had a point dose maximum to the spinal cord/cauda equina <27.5 Gy. No patient experienced treatment-related myelopathy. The most common toxicities were fatigue (23.3%), pain flare (14.0%), and nausea (8.1%). There were no grade 3 toxicities. One-year local control was 80.6%, and 1-year OS was 38.4%. Higher Karnofsky performance status (P = .001) and radiosensitive tumor histology (P = .014) were significant predictors for better OS. CONCLUSIONS: Our single-institutional retrospective analysis of patients with spinal metastasis suggested that palliative EBRT to 25 Gy in 5 fractions is safe, with a low toxicity profile and minimal risk for myelopathy with an achievable dose maximum to the spinal cord and cauda equina ≤27 Gy (equivalent total dose in 2-Gy fractions ≤50 Gy), and it may provide durable palliation and local control in cases where stereotactic body radiation therapy may not be indicated. Elsevier 2022-02-04 /pmc/articles/PMC8917266/ /pubmed/35287317 http://dx.doi.org/10.1016/j.adro.2022.100906 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Scientific Article Shin, Jacob Y. Mathis, Noah J. Wijetunga, Neil Ari Yerramilli, Divya Higginson, Daniel S. Schmitt, Adam M. Gomez, Daniel R. Yamada, Yoshiya J. Yang, Jonathan T. Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title | Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title_full | Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title_fullStr | Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title_full_unstemmed | Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title_short | Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy × 5 Fractions) for Spine Metastasis |
title_sort | clinical outcomes of dose-escalated hypofractionated external beam radiation therapy (5 gy × 5 fractions) for spine metastasis |
topic | Scientific Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917266/ https://www.ncbi.nlm.nih.gov/pubmed/35287317 http://dx.doi.org/10.1016/j.adro.2022.100906 |
work_keys_str_mv | AT shinjacoby clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT mathisnoahj clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT wijetunganeilari clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT yerramillidivya clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT higginsondaniels clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT schmittadamm clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT gomezdanielr clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT yamadayoshiyaj clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis AT yangjonathant clinicaloutcomesofdoseescalatedhypofractionatedexternalbeamradiationtherapy5gy5fractionsforspinemetastasis |